Our findings suggest that BMP2 signaling in glioblastoma does not follow a unidirectional paradigm but may exhibit dual or paradoxical roles depending on molecular subtype, tumor microenvironment, and differentiation status. The gene discussed is BMP2; the disease is neoplasm.